Introduction
Cells that have sustained DNA damage constitute a threat to the organism. This is because damage to the DNA can result in genetic changes, particularly mutations, which can contribute to the development of diseases such as cancer. Mammalian cells have evolved a variety of mechanisms to minimize the sequelae of DNA damage. One of these mechanisms involves growth-arrest followed by DNA repair, and another involves cell death by apoptosis. Thus, ®broblasts exposed to DNA damage can utilize the growth-arrest/DNA repair response, a response that is frequently dependent upon expression of the wild-type p53 gene product (Kastan et al., 1991a (Kastan et al., , 1992 . Cells of lymphoid and myeloid origin, on the other hand, frequently undergo rapid apoptosis upon exposure to DNA damaging agents.
The response to DNA damage can be altered when cells undergo transformation. Thus, transformation of ®broblasts with the adenovirus early region 1A (E1A) gene causes them to convert from the growth-arrest/ DNA repair response to the apoptosis response to DNA damage (Lowe et al., 1993a) . The response to DNA damage can also be in¯uenced by tumor suppressor genes. Thus, loss of the p53 tumor suppressor gene, in E1A-transformed ®broblasts, causes a reduction in the apoptotic response (Lowe et al., 1993a) . While the response to DNA damage is in some cases dependent upon p53 (e.g. in E1A-transformed ®broblasts or normal thymocytes), in other cases it is independent of p53 (e.g. in lymphoma cells or activated lymphocytes (Lowe et al., 1993a,b; Strasser et al., 1994) . In sum, dierent cell types exposed to DNA damage can undergo either growtharrest or apoptosis, which may occur through p53-dependent as well as -independent pathways. These responses serve to prevent the propagation of DNA damage to daughter cells and thus to limit the generation and stable transmission of mutations, such as mutations that could promote neoplastic transformation.
The molecular basis for the response to DNA damage is beginning to be understood. As expected from the involvement of p53 in this response, downstream targets of p53 appear to be involved (Kastan et al., 1992; Miyashita and Reed, 1995) . These targets include GADD45, a growth-arrest and DNA damage-inducible gene, p21 Zhan et al., 1994a Zhan et al., ,b, 1995 Selvakumaran et al., 1994; Miyashita et al., 1994) . Gadd45 and p21 Cip1/Waf1 cause growth suppression and thus may serve as downstream eectors of the growth-arrest response (Xiong et al., 1993; Zhan et al., 1994c Zhan et al., , 1995 . Mdm2 blocks the eects of p53 and thus may be involved in a feedback loop that regulates the duration of p53-induced growth-arrest Chen et al., 1994; Finlay, 1993; Oliner et al., 1992; Wu et al., 1993; Momand et al., 1992) .
A variety of genes also appear to be involved in the apoptosis response to DNA damage. Here, genes involved in the control of cell viability -notably members of the BCL2 family -appear to play a role. In the ML-1 human myeloblastic leukemia cell line, high doses of ionizing radiation (IR) cause DNA damage followed by apoptotic cell death. As an early event in this process, these doses cause a rapid increase in the BCL2 family member BAX (within 4 h) and a decrease in BCL2, in addition to increases in p53, GADD45, p21 CIP1/WAF1 and MDM2 (Kastan et al., 1991a; Miyashita et al., 1994; Miyashita and Reed, 1995; Selvakumaran et al., 1994; Zhan et al., 1994a,b) . The increase in BAX mRNA is dependent upon the presence of a functional p53 gene in ML-1 and other cell types Miyashita and Reed, 1995; Selvakumaran et al., 1994; Zhan et al., 1994b) . Furthermore, the increase in BAX occurs only in cells that undergo apoptosis in response to IR and not in cells that undergo growth arrest/DNA repair or that are radioresistant (Zhan et al., 1994b; Kitada et al., 1996) . These changes in expression of members of the BCL2 family probably contribute to the ensuing apoptosis as an increase in Bax relative to Bcl2 can promote Bax : Bax homodimerization and cell death (Oltvai et al., 1993; Yang and Korsmeyer, 1996; Yin et al., 1994) . Conversely, an increase in Bcl2 can inhibit the apoptotic response to DNA damage (FukunagaJohnson et al., 1995) .
Another member of the BCL2 family, MCL1, was discovered based upon increased expression in ML-1 cells undergoing dierentiation in response to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA) (Kozopas et al., 1993) . Like Bcl2 (Hockenbery et al., 1990; Vaux et al., 1988) , transfection with Mcl1 can delay cell death under conditions that cause apoptosis (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997) . This has been observed upon transfection of hematopoietic cells as well as Chinese Hamster Ovary (CHO) cells. In the latter, it was found that the delay of apoptosis produced by Mcl1 was not as prolonged as that produced by Bcl2 (Reynolds et al., 1994 (Reynolds et al., , 1996 . Another subtle dierence between Mcl1 and Bcl2 was seen in studies of intracellular distribution, where the distributions of Mcl1 and Bcl2 were found to be overlapping but not identical (Yang et al., 1995b) . Thus, Mcl1 exhibits similarities to as well as dierences from Bcl2, as do other members of this gene family (reviewed in Cory, 1995; Craig, 1995) .
We have recently found that expression of MCL1 increases upon exposure of ML-1 cells to certain cytotoxic agents (colchicine, vinblastine, and cycloheximide), as well as upon exposure to dierentiationinducing or cytotoxic concentrations of TPA . Under both dierentiation-inducing and cytotoxic conditions, the expression of MCL1 increased rapidly, elevation of the MCL1 mRNA being seen within 1 ± 3 h and that of the protein at 3 ± 6 h (Kozopas et al., 1993; . The increase in MCL1 preceded dierentiation or death, which were detectable morphologically within 1 day and continued over approximately 3 days. The cytotoxic agents previously found to increase expression of MCL1 are classical DNA damaging agents, although they do appear to cause cell death by apoptosis. Because of this fact, and because other members of the BCL2 family are involved in the response to DNA damage, we set out to monitor the response of MCL1 to a variety of known DNA damaging agents. Our expectation was that such agents might cause an increase in the expression of MCL1 in conjunction with the apoptotic response. This expectation was born out in that we observed a rapid increase in expression of MCL1 in ML-1 and other cell lines susceptible to the apoptosisinducing eects of DNA damaging agents. Thus, cells in the initial stages of the apoptotic response to DNA damage exhibited an increase in expression of MCL1, which was found to be p53-independent, in addition to the increase in BAX, which is p53-dependent. The increase in MCL1 contrasts with the decrease in BCL2 previously reported (Zhan et al., 1994b) . Taken as a whole, these ®ndings underscore the fact that various genes in the BCL2 family have a role in the response to DNA damage. They further suggest that MCL1 may participate in both the cell dierentiation and death responses, opening a possible new dimension to our understanding of the function of MCL1.
Results
To begin to test for eects of DNA damaging agents on expression of MCL1, we exposed cells to a cytotoxic dose of IR and used Northern blotting to assay for the MCL1 mRNA. As shown in Figure 1 , we observed a dramatic increase in both MCL1 transcripts in ML-1 cells (3.8 and 2.4 kb; Kozopas et al., 1993) . We also observed an increase in the WMN Burkitt's lymphoma cell line, which is similar to ML-1 in that p53 is wildtype and the cells respond to IR with increases in GADD45 and BAX (Zhan et al., 1996) . We next used the ML-1 cell line to monitor the time course of the IRinduced increase in MCL1 mRNA. The increase in MCL1 occurred rapidly and was transient, reaching a peak within approximately 4 h and returning to near baseline within 12 ± 24 h ( Figure 2A , ®lled circles). The increase in expression of MCL1 thus occurred within the same time frame as the initiation of DNA digestion, which becomes apparent within 4 h (Zhan et al., 1994a) . The increase in MCL1 mRNA occurred prior to the appearance of overtly dead cells, which begin to come into evidence at approximately 1 day ( Figure 3A) . The rapid increase in MCL1 in response to IR is reminiscent of the increase previously reported for a variety of other genes, including GADD45, p21
, MDM2, and BAX (Zhan et al., 1994b . However, there may be subtle dierences among the various genes; for example, the elevation in BAX is at a peak at 8 h, at which time MCL1 is beginning to decline (Figure 2A and legend, note that we assayed expression of MCL1 using the same samples that had previously been assayed for expression of BAX). The increase in MCL1 in response to IR is also reminiscent of the increase seen with cytotoxic concentrations of colchicine, vinblastine, or TPA . Taken together, these ®ndings indicate that expression of MCL1 can increase in response to DNA damage and/or cytotoxic stress, in addition to during dierentiation-induction.
We next exposed ML-1 cells to a range of dierent doses of IR, in order to further characterize eects on expression of MCL1. With increasing dose, we observed progressive increases in the MCL1 mRNA ( Figure 2B ). Thus, a moderate increase in MCL1 mRNA (2.2-fold) was seen with a dose of 2 Gray, which causes moderate cell death at 1 day ( Figure 3B ) and which would be expected to allow *37% cell + RNA from these cells was used in quantitative dot blot analysis with MCL1 as probe. The results with the MCL1 probe (plotted as fold-induction over baseline (left ordinate)) were compared to previous results using GADD45 and BAX (from Zhan et al., 1994a,b ; plotted as % of maximal induction (right ordinate)). Expression of MCL1 was assayed using the same blots that had previously been used for monitoring expression of BAX (Figure 2 of Zhan et al., 1994b) . Data on expression of GADD45 is from Zhan et al. (1994a) . (B) Eect of various doses of IR on expression of MCL1. ML-1 cells were exposed to the indicated doses of IR and harvested 4 h later. MCL1 expression was assayed as in A. Expression of MCL1 was assayed using the same blots that had previously been used for monitoring expression of BAX (Figure 2 of Zhan et al., 1994b) . Data on expression of GADD45 is from Zhan et al. (1994a) . (C) Time course of changes in expression of MCL1 mRNA after exposure to u.v. irradiation. Cells were irradiated with 14 J/m 2 (254 nm source) and MCL1 mRNA expression was assayed at various times as in A MCL1 is induced by DNA damage Q Zhan et al survival in a clonogenic assay (D 37 dose; Zhan et al., 1994a) . A further increase in MCL1 mRNA (*fourfold) was seen with a higher dose of 5 Gray, which causes somewhat more cell death at 1 day and which would be expected to result in the loss of clonogenic proliferation potential in nearly the entire cell population (Zhan et al., 1994a) . A small further increase in MCL1 was seen with further increases in IR dose ( Figure 2B ). In contrast to MCL1, BAX exhibits a near-maximal increase at the 2 Gray dose and essentially no further increase is seen with doses of 5 Gray and higher (Zhan et al., 1994b;  Figure 2 and legend, note that we assayed expression of MCL1 using the same samples that had previously been assayed for expression of BAX). In previous experiments, GADD45 had been found to exhibit progressive increases in expression with increasing dose (Zhan et al., 1994a) . Although the samples assayed in the present experiment for expression of MCL1 were not the same samples that had previously been assayed for GADD45, increases in GADD45 with increasing IR doses of 2 ± 20 Gray has been a consistent ®nding (as assayed at a 4 h time point). Similarly, p21 WAF1/CIP1 exhibits increasing expression with increasing IR dose and behaves in other respects like GADD45 . Overall, the dose/response curve for increasing expression of MCL1 mRNA did not reach a maximum at the 2 Gray IR dose as did the curve for BAX, but rather showed further increases at doses of 55 Gray, in a fashion somewhat reminiscent of GADD45.
To con®rm and extend the ®nding of increased MCL1 mRNA, we monitored expression of the Mcl1 protein. We ®rst examined cells at various times after exposure to IR. As expected, we observed an increase in the Mcl1 protein (Figure 4a This increase was found to occur 4 ± 6 h after IR exposure. A non-speci®c band (indicated with a straight line in Figure 4a ) did not show any increase at these times, suggesting that dierences in loading or transfer did not account for the increased amount of Mcl1 protein. We next examined cells exposed to various doses of IR ( Figure 4b ). We observed the increase in Mcl1 protein to be dose-dependent as assessed 6 h after exposure to IR (Figure 4bii ), with no increase being seen at 3 h ( Figure 4bi ). The increase in the Mcl1 protein occurred in the absence of any change in levels of the Bcl2 protein ( Figure  4biii ); this could relate to the long half-life of the Bcl2 protein and references therein), since the BCL2 mRNA is known to decrease at these times (Zhan et al., 1994b) . The increase in the Mcl1 protein was maximal (*®vefold) at an IR dose of 5 Gray, with less of an increase being observed not only at lower doses (2.8-to threefold at 1 ± 2 Gray) but also at higher doses (4.4-and 3.5-fold at 10 and 20 Gray, respectively). This reduction in the eect of high IR doses on Mcl1 protein expression was surprising in view of the ®ndings regarding the MCL1 mRNA ( Figure 2B ). However, the reduced eect of high IR doses on Mcl1 protein expression was a very consistent ®nding, although the magnitude of the change seen at these doses was variable. For example, in the experiments shown in Figure 4bii , only a moderate reduction in Mcl1 was seen at the 20 gray dose while, in other experiments, no increase in Mcl1 was observed at this dose (data not shown). This eect seen at high doses of IR could potentially relate to toxicity (Figure 3) and/or to a toxicity related instability to synthesize new proteins. However, in one experiment in which little or no increase in Mcl1 was seen after a 20 Gray IR dose, we observed a robust increase in the p21
Cip1/Waf1 protein (data not shown). In sum, the dose/response curve for expression of the Mcl1 protein appeared to be biphasic, and the diminishment of eects seen at higher doses did not appear to relate to an inability of the cells to synthesize new proteins as could potentially occur in association with cytotoxicity.
The increase in expression of BAX seen with IR is p53-dependent and occurs only in association with the apoptosis response (Zhan et al., 1994b) . To assess whether MCL1 is similar to BAX in these respects, we examined a panel of human cell lines that exhibit dierences in p53 status and dierences in sensitivity to the apoptosis-inducing eects of IR. As shown in Table  1 , the increase in MCL1 mRNA in response to IR appeared to be independent of p53 status as it could be seen in cells containing an intact, functional p53 (e.g. ML-1) as well as in cells lacking p53 (e.g. HL-60) or containing a mutant form of p53 (e.g. SW480). This provides a contrast with BAX, as well as with GADD45 and p21
CIP1/WAF1
, which increase only in cells that contain an intact, wild-type p53 (Zhan et al., 1994a (Zhan et al., ,b, 1995 . Although the increase in MCL1 occurred in a manner independent of p53, it did not occur in all cell lines tested. Instead, an increase was seen primarily in cells that undergo rapid apoptosis in response to IR, but not in cells that respond by primary growth-arrest rather than apoptosis. Thus, where p53 was intact, an increase in MCL1 mRNA was seen in a variety of lymphoid and myeloid lines that undergo apoptosis upon exposure to IR (Table 1 , upper portion; 4twofold increase in ML-1, NL2, FWL, WMN, AG876). However, no increase in MCL1 occurred in ®broblasts or in RKO colorectal carcinoma cells, which do not undergo rapid apoptosis in response to IR. No increase was seen in the MCF-7 breast carcinoma cell line, which could relate to the fact that its apoptotic response to IR is weak compared to the much more prolonged response seen in the myeloid and lymphoid lines (Zhan et al., 1994b) . Where p53 was abnormal, a 4twofold increase in MCL1 similarly occurred in cell lines that undergo rapid apoptosis in response to IR (Table 1 , lower portion). Overall, the IR-induced increase in MCL1 appeared to be dierent from the increase in BAX in being independent of p53 status. However, the increase in MCL1 appeared similar to that of BAX in that both are linked to the apoptosis response.
To assess the generality of the response of MCL1 to genotoxic stress, we used two other agents that cause DNA damage -far u.v. irradiation and the chemical mutagen methylmethane sulfonate (MMS). ML-1 cells exhibited an increase in MCL1 with both of these agents ( Figure 2C and Table 2 ). An increase was also seen in other cell lines, including cells that had not exhibited an increase with IR (i.e. MCF-7 cells and RKO cells treated with MMS; Table 2 ). This may be because u.v. irradiation and MMS produce considerably more lesions in DNA than equitoxic doses of IR (Holbrook and Fornace, 1991) and this dose of MMS in particular can trigger apoptosis even in extremely apoptosis-resistant lines such as RKO (data not shown). In both MCF-7 and RKO cells, we teseted the eects of expression of the Human Papilloma Virus E6 gene product, which blocks p53 function including p53-mediated apoptosis. Blockage by E6 of the ability of cells to undergo apoptosis in response to genotoxic stress (in MCF-7E6 and RKO-6 cells, respectively) markedly reduced the MCL1 response. Since E6 blocks both p53 function and apoptosis, we cannot determine whether the reversal of the MCL1 response relates strictly to the inhibition of apoptosis or, alternatively, whether the increase in MCL1 might be dependent upon p53 in MCF-7 and RKO in contrast to the situation in HL-60 and SW480 (Table 1) . Nonetheless, the ®nding that the E6 gene product inhibits both the increase in MCL1 expression and the apoptotic response to IR further strengthens the link between these two events. ) was included on this blot (not shown) and was found to exhibit an *6.3-fold increase in Mcl1. The increases in Mcl1 seen at 4 and 6 h after IR were estimated to be *2.1 and 3.1-fold, respectively. (b) ML-1 cells were exposed to various doses of ionizing radiation (0 ± 20 Gray, as indicated) and assayed for expression of the Mcl1 protein at 3 h (i) or 6 h (ii). The equivalent of 1610 6 cells were loaded in each lane and Western blotting was carried out as described above for A. A sample of cells incubated with or without TPA was included on the blot (lanes 1 ± 2) and was found to produce an *®vefold increase in Mcl1. In (iii) the blot shown in (ii) was stripped and reprobed for the Bcl2 protein Discussion MCL1 was initially identi®ed as a gene upregulated during the induction of dierentiation in ML-1 cells exposed to TPA (Kozopas et al., 1993) . Similarly, MCL1 expression has recently been found to increase when these cells are exposed to cytotoxic drugs . However, while the increase is seen with some drugs (e.g. colchicine, vinblastine, cycloheximide), it is not seen with others (e.g. araC, daunorubicin, taxol; . Therefore, in work presented in this paper, we set out to monitor the eects of additional cytotoxic agents, speci®cally DNA damaging agents. We found expression of MCL1 to increase in response to a variety of such agents, including radiation and the chemical mutagen MMS. Our ®ndings reinforce the fact that an increase in the expression MCL1 can be seen during cytotoxic stress as well as during dierentiation-induction. Further, they clearly establish MCL1 as a DNA damage-inducible gene, which increases along with other genes in this class such as GADD45, p21
, MDM2, and BAX. This result, along with previous work (Zhan et al., 1994a (Zhan et al., ,b, 1995 , indicates that cells respond to DNA damage with a rapid readjustment in the pro®le of expression of a variety of genes, including MCL1 and other members of the BCL2 family.
The increase in MCL1 expression induced by DNA damaging agents is tightly linked to apoptosis in that the increase only occurs in cells that undergo apoptosis in response to these agents. Transfection of these cells with the Human Papilloma Virus E6 gene reverses the increase in MCL1 and the apoptotic response to DNA damage, providing further evidence for a link between these two events. A similar link can be seen between the increased expression of MCL1 produced by colchicine or vinblastine and the apoptotic eects of these agents. This has been seen in ML-1 and K-562 cells, which are comparable to the cells examined here before and after transfection with E6 in that ML-1 contains wild-type p53 while K-562 is p53-null. As reported previously, both ML-1 and K-562 exhibit increased expression of MCL1 upon exposure to TPA . ML-1 cells also exhibit increased expression upon exposure to colchicine or vinblastine, and these cells subsequently undergo apoptosis . In contrast, K-562 cells do not exhibit increased expression upon exposure to either of these agents, even at very high doses, and do not undergo apoptosis (KJ Townsend and RW Craig, unpublished data). In sum, the link between increased MCL1 expression and the apoptosis response is seen with both the DNA-damaging and the cytoskeletal disrupting agents. Interestingly, an increase in MCL1 is not seen with all cytotoxic or apoptosis-inducing agents. For example, as reported previously , no increase in MCL1 is seen upon exposure of ML-1 cells to cytotoxic doses of araC or daunorubicin. This suggests that cell death per se may not be the trigger for increased expression of MCL1. Furthermore, beyond being increased by the DNA damaging agents tested here, expression of MCL1 is also increased by some agents that do not cause extensive DNA damage (i.e. colchicine and vinblastine ). This suggests that DNA damage may, similarly, not be the proximal trigger for increased expression. Instead a downstream pathway triggered by both DNA damaging agents and cytoskeletal disrupting agents might be speculated to transduce the signal for increased MCL1 expression. Results analogous to these with cytotoxic agents have also been obtained using dierentiation-inducing agents. Here, expression of MCL1 is increased with inducers of monocyte/ macrophage dierentiation but not by retinoic acid an inducer of granulocyte dierentiation . We are currently initiating studies on the regulation of expression of MCL1. Our goal is to de®ne the pathway(s) involved in the increase in expression seen with speci®c dierentiation-inducing and cytotoxic agents.
It is interesting to compare the response of the MCL1 to DNA damage and that of BAX (Zhan et al., 1994b) , the other member of the BCL2 family that is known to be a DNA damage-inducible gene. The responses of MCL1 and BAX are broadly similar in time course in that expression of both increases within hours and subsequently returns to near baseline within a day, although the peak in expression of BAX occurs somewhat later than the peak in MCL1. Another similarity between MCL1 and BAX is that increased expression occurs in cell lines that undergo rapid apoptosis in response to DNA damage but not in lines that are resistant to DNA damage-induced apoptosis. In contrast, a dierence between MCL1 and BAX is that the increase in MCL1 is not dependent upon p53 while the increase in BAX may be directly mediated through transcriptional activation by p53 (Miyashita and Reed, 1995) . In sum, the responses of MCL1 and BAX are similar in some aspects and dierent in others. Although both are associated with apoptosis, the increase in BAX is p53-dependent while the increase in MCL1 can occur in a p53-independent manner.
The ®nding that MCL1 expression increases in cells poised to undergo apoptosis (e.g. in response to DNA damage) may appear paradoxical in view of our previous results from transfection experiments. Transfection with Mcl1 has not been associated with the promotion of cell death (Bodrug et al., 1995; Reynolds et al., 1994 Reynolds et al., , 1996 Zhou et al., 1997) . Instead, Mcl1 can promote cell viability, although the eects of Mcl1 may be more short-term than the eects of Bcl2 (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997) and Mcl1 is turned over more rapidly (Yang et al., 1995b) . In fact, we have recently speci®cally examined the eect of transfection with MCL1 on apoptosis induced by DNA damaging agents and have found that MCL1 can provide protection from the eects of such agents (e.g. from u.v. radiation; Zhou et al., 1997) . There are two possible mechanisms that might underlie the apparent dichotomy between the results from transfection experiments and those on the pattern of expression. One possible mechanism relates to the fact that Mcl1 may act as a short-term regulator of cell viability, as we have previously suggested (Reynolds et al., 1994; Yang et al., 1995b) . In the case of exposure to DNA damaging agents, cells exhibit an increase in expression of MCL1 and a decrease in BCL2, along with an increase in BAX (Zhan et al., 1994b) . In eect, they appear to upregulate a potential death regulator (BAX) while at the same time upregulating a labile mechanism capable of short-term protection of viability (MCL1). This strategy could allow the cells a window of time in which to assess the DNA damage and make a decision as to how to respond, where the response could be either to undergo apoptosis or to upregulate longer term protective mechanisms.
We note that very recent ®ndings indicate that BCLX, another viability-promoting member of the BCL2 gene family, also increases in cells undergoing apoptosis in response to DNA damage (Zhan et al., 1996 in press). Interestingly, the structure of this BCL2 family member reveals similarity to the bacterial colians (Muchmore et al., 1996) which are secreted during the SOS response in Escherichia coli (Stroud, 1995) , providing an analogy to the upregulation of BCL2 family members during the DNA damage response in mammalian cells. In a fashion somewhat analogous to the upregulation of both viabilitypromoting molecules (i.e. MCL1) and death-promoting molecules (e.g. BAX), cells exposed to IR exhibit an upregulation of both p53 and MDM2, the latter being a negative regulator of p53 Chen et al., 1994; Finlay, 1993; Momand et al., 1992; Oliner et al., 1992; Perry et al., 1993; Wu et al., 1993; Xiong et al., 1993) . In this case, it has been postulated that MDM2 might serve as part of a feedback loop, limiting the duration of growth-arrest by p53.
Another possible interpretation of the above apparent paradox is that the ®ndings described here may serve as an indication that Mcl1 has a role in cell death, in addition to the function in enhancing viability seen upon transfection. There is precedent for this type of dual role with other members of the Bcl2 family. For example, the recently identi®ed family member Bak can promote cell death in some cell types, while promoting cell viability in others (Chittenden et al., 1995; Farrow et al., 1995; Kiefer et al., 1995) . Furthermore, Bax has been speculated to have a role in promoting cell death when present as a homodimer, while having a role in maintaining cell viability when present as a heterodimer with Bcl2 (Yang and Korsmeyer, 1996) . Finally, transfection with Bax has recently been reported to be capable of promoting cell viability in neuronal cells under certain conditions (Middleton et al., 1996) . In the case of Mcl1, the presence or absence of some other member of the Bcl2 family that interacts with Mcl1 could in¯uence the ®nal outcome, whether it be viability or death. In ML-1 cells, expression of MCL1 increases in response to both dierentiation-inducing and cytotoxic signals; however, BCL2 levels remain constant with the dierentiationinducer TPA, but decline with cytotoxic IR (Yang et al., 1995b; Zhan et al., 1994b) . This dierence in BCL2, along with the increase in BAX seen upon IR, could signify that the milieu in which MCL1 is expressed alters its function and thus in the case of TPA the cells remain viable while in the case of IR they die. In addition to genes in the BCL2 family, many other genes change in expression upon exposure to TPA or IR. An example of a rather subtle dierence between these two agents is the change in expression of p53, which increases rapidly upon exposure to IR but much more slowly upon exposure to TPA (Kastan et al., 1991a,b) . Thus, upregulation of MCL1 by IR, in the context of other growth-arrest and DNA damage-inducible genes (e.g. p53, GADD45, p21
, and MDM2, as well as BAX), might have a role in bringing about loss of proliferative potential and/or cell death, despite the fact that transfection with MCL1 alone enhances cell viability. The present data do not allow us to discriminate between the above two possible solutions to the apparent paradox between the results from transfection versus expression studies on MCL1. However, the fact that the increase in the Mcl1 protein is diminished at high doses of IR is more consistent with the former possibility, that is that the increase in Mcl1 seen at moderate IR doses is related to the established short term eects of the gene in promoting cell viability (Reynolds et al., 1994 (Reynolds et al., , 1996 Zhou et al., 1997) .
Overall, the ®ndings presented here demonstrate that an increase in MCL1 expression can harbinger either cell dierentiation or cell death. These ®ndings thus serve to point out a distinction between the pattern of expression of MCL1 and that of BCL2, which does not increase during dierentiation and which decreases in cells exposed to DNA damage (Zhan et al., 1994b) . These ®ndings also serve to underscore the ®ne distinction between dierentiation and death. Terminal dierentiation is generally followed by death, although the interval between the two can be short (as in the case of granulocytes), or long (as in the case of neurons). Conversely, death can serve to abort cell dierentiation, the most well known example being selection in the immune system where undesirable clones can be eliminated at an early stage of dierentiation. In view of the close connection between these two events, the fact that MCL1 expression increases in both cases is perhaps not such a paradoxical ®nding after all.
Materials and methods
Cell culture and application of DNA damaging agents Cells were cultured as described previously and various DNA damaging agents, including IR, u.v. irradiation, and methylmethane sulfonate, were applied as described previously (Zhan et al., 1994a) . Cell viability was monitored by trypan blue dye exclusion as described previously .
Analysis of expression of MCL1
For assay of MCL1 mRNA levels, poly(A) + RNA was isolated and subjected to Northern analysis or quantitative dot blot as described previously (Zhan et al., 1994a) . The probe used was an MCL1 cDNA containing the entire coding region of MCL1 (p3.2; Kozopas et al., 1993) , which had been labeled by the random primer method (Feinberg and Vogelstein, 1993) as in previous work . Northern blot analysis was ®rst performed, both to assess changes in MCL1 mRNA level and as an indication of whether the expected MCL1 mRNA bands (3.8 and 2.4 kb; Kozopas et al., 1993) were present and intact as opposed to degraded. Quantitative dot blot analysis was then performed, using hybridization at high stringency as described previously (Hollander and Fornace, 1989) ; these blots were then scanned using a Betascope blot analyser (Betagen Inc.) and at least four dot-blot determinations for each point were included in the analysis. For the purpose of standardization, the relative poly(A) + content of each RNA sample in the dotblot analysis was estimated by using a labeled polythymidylic acid probe; this correction was small and usually varied by less than 25%. With this quantitative dot blot approach, the values for relative RNA are directly proportional to RNA abundance and dierences of 1.5-fold or more can be reliably measured Fornace, 1989, 1990 ) results obtained with this sensitive approach agree well with those obtained by RNAse protection determinations (Zhan et al., 1994a) .
For assay of the Mcl1 protein, Western blots (1610 6 ML-1 cell equivalents/lane) were carried out as described elsewhere (Zhou et al., 1997) , using an antibody to Mcl1 that has been previously characterized (Yang et al., 1995b) . With some blots, the extent of the increase in Mcl1 was estimated by densitometry using a Personal Densitometer from Molecular Dynamics Inc. Some blots were stripped and reprobed for the Bcl2 protein using methods described elsewhere (Zhou et al., 1997) .
